Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)…
DUBAI, UAE, Feb. 7, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to announce…
Study examines the untapped potential of workers in the first of a series of studies comprising the refreshed "People at…
Study examines the untapped potential of workers in the first of a series of studies comprising the refreshed "People at…
85% of global enterprises are actively using or testing generative AI in at least one function SAN FRANCISCO, Nov. 14,…